Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.78 CHF | +2.73% | +5.50% | -0.31% |
Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.31% | 118M | |
+16.93% | 79.28B | |
+7.97% | 8.74B | |
-17.73% | 4.84B | |
+56.03% | 4.74B | |
+1.31% | 3.87B | |
+18.99% | 2.46B | |
-25.43% | 2.18B | |
+14.61% | 2.09B | |
-37.31% | 1.98B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals Wins EU Nod for Duchenne Muscular Dystrophy Drug